CAIR Launches CARES Copilot 1.0: A Revolutionary AI Chatbot for Medical Diagnosis and Treatment
The Centre for Artificial Intelligence and Robotics (CAIR), part of the Chinese Academy of Sciences...
The Centre for Artificial Intelligence and Robotics (CAIR), part of the Chinese Academy of Sciences...
VIVA Biotech Holdings (HKG: 1873), a China-based Contract Research Organization (CRO), has entered into a...
Antengene Corporation Ltd (HKG: 6996), a leading biopharmaceutical company based in China, has announced that...
CSPC Pharmaceutical Group Ltd (HKG: 1093), a prominent China-based biopharmaceutical company, has received approval from...
3SBio Inc. (HKG: 1530), a leading China-based biopharmaceutical company, has reported its 2023 financial results,...
Innovent Biologics Inc. (HKG: 1801), a China-based biotechnology firm, has released its 2023 financial report,...
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company based in China, has...
Zuellig Pharma, a Singapore-based healthcare solutions provider, has announced the expansion of its commercialization agreement...
CSPC Pharmaceutical Group Ltd (HKG: 1093), a leading pharmaceutical company based in China, has received...
Novo Nordisk (NYSE: NVO), a Denmark-based leader in diabetes care, has announced a substantial investment...
Suzhou Porton Biologics Ltd, a China-based Contract Development and Manufacturing Organization (CDMO), has entered into...
The National Healthcare Security Administration (NHSA) has announced an expansion of its medical services pricing...
Carbogen Amcis, a Swiss firm specializing in active pharmaceutical ingredients (APIs) and pharmaceutical process development,...
Everest Medicines (HKG: 1952), a leading China-based biotechnology company, has announced two significant appointments to...
WuXi XDC (HKG: 2268), a joint venture between Wuxi Biologics (HKG: 2269) and WuXi STA,...
Shanghai Winpu Technology Co., Ltd., a specialist in medical-grade polymer materials based in China, has...
Everest Medicines (HKG: 1952), a China-based biotechnology company, has received marketing approval from the Singapore...
Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607), one of the leading pharmaceutical giants in China,...
AstraZeneca (AZ; NASDAQ: AZN), the UK-based pharmaceutical giant, has announced its intention to acquire Fusion...
China Grand Pharmaceutical and Healthcare Holdings Ltd (HKG: 0512; CGP) has reported its financial results...